Strengthened Safety Warnings on GLP-1 and GLP-1/GIP Receptor Agonists The MHRA has issued updated safety guidance on GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists, with strengthened warnings regarding the risk of acute pancreatitis, including necrotising and fatal cases. What You Need to Know Product information for all GLP-1 and GLP-1/GIP agonists has been updated […]